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Chapter 1 reviews the 1 i terature on the debate over 
flexibility and its relevance to the medical instruments and 
supply industry. 
Chapter 2 briefly introduces the methodology used in this 
research. 
Chapter 3 reviews factors influencing the development of 
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today. 
Chapter 5 analyzes flexibility in the industry by 
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Chapter 6 discusses policy implications. 
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Chapter one 
Introduction to the Flexibility Debate 
1.1 Introduction 
Since the early 1980's, a debate has raged in planning, 
economics, geography, and political science about changes in 
capitalist industry's organization. The dazzling variety of 
industrial changes during the last quarter century make it 
difficult to grasp the controversy. However, this debate 
centers on a series of dichotomies: batch vs mass production, 
disintegrated vs integrated firms, economies of scope vs 
economies of scale, and "flexible specialization" vs "rigid 
fordist production". The critical argument focuses on ( l} 
whether or not there is a new regime of flexible accumulation 
(conventionally called flexibility) and, (2) if so, whether or 
not this new regime could replace or substitute for the regime 
of Fordist accumulation (conventionally called Fordism) and 
become the dominant form of economic organization in market 
society. 
1.2 The Flexibility Debate 
To understand this debate, one must distinguish the main 
features of these two regimes. Albrechts and Swyngedoun 
(1988:9-10} point out five elements for comparing these two 
regimes: the production process, labor, space, the State, and 
ideology. The main points of their comparison are summarized 
in Table 1. 1. 
1 
The 
Production 
Process 
Labor 
Space 
The State 
Ideology 
Table 1.1 
Fordism vs Flexibility 
Ford ism 
Mass production 
Uniform 
Supply driven 
Vertical integration 
Single task 
Job specialization 
No job training 
No job security 
Decentralization 
Suburbanization 
Segmented labor markets 
Regulation 
Rigidity 
Socialized welfare 
Firm-financed R&D 
Indirect intervention 
in market 
Modernism 
Socialization 
Rationalism 
Totality/Structural 
Specificity/Adaptation 
reform 
Flexibility 
Small batch 
Flexible 
Demand driven 
Vertical 
disintegration 
Multiple tasks 
No job demarcation 
Long-on job training 
High job security for 
permanent workers 
Cluster & 
Agglomeration 
Urban Center 
Labor market 
diversified 
Deregulation 
Flexibility 
Privatized welfare 
State-financed R&D 
Direct intervention 
in market 
Post-Modernism 
Individualization 
Deconstructionism 
Source: Albrechts & Swyngedoun (1988:9-10). 
2 
Many scholars (Feldman, 1989a, 1989b, 1989c, 1990; Piere 
& Sabel 1984; Scott 1988; etc.) argue that this debate is 
rooted in the theoretical territory of the French 
Regulationist School. This school of thought argues that 
stable growth in capitalist economies requires an extensive 
assortment of non-market rules, regulations, norms, 
organizations and operations which collectively form a "regime 
of accumulation". Without such a presumption, the whole 
debate would become moot. 
Under this assumption, Piere and Sabel first presented 
their seminal and stimulating The Second Industrial Divide in 
1984, and pioneered the dispute over flexibility. In their 
opinion, Fordism failed because it could no longer handle the 
growing volatility and instability generated by escalated 
international competition. The large and stable markets that 
mass production needs to achieve economies of scale hardly 
exist today. Therefore, a new type of production method, 
"flexible specialization'', a term indicating spatially dense 
networks of relating small, vertically disintegrated firms, is 
emerging to adjust the old production system to the new 
environment. 
Four traits characterize flexible specialization (FS) 
(Sabel & Zeitlin, 1985:144, Feldman & Yuan 1990:4). First, FS 
produces a wide range of products for highly differentiated 
markets so that changing demands can be met. Second, FS is 
characterized by small and medium-sized firms. Third, FS is 
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technologically dynamic, as reflected in the firm's ability to 
alter product mix and to introduce new product and process 
innovations. Finally, firms engaged in FS cooperate with each 
other and benefit from external economies of scale which 
support vertically disintegrated firms. Planners are 
particularly interested in: (1) flexibility and regional 
development and (2) flexibility and the labor process. 
1.3 Flexibility and Regional Development 
Flexibility and its relationship to regional development 
have attracted the attention of theoreticians from the very 
beginning. Scott (1988) argues that a transition has occurred 
during the last decade or so and that fordism is being 
supplanted by more flexible forms of production. Scott points 
out that the mode of social regulation that sustained f ordist 
production is no longer strong enough to pin up this old 
regime. Factors contributing to this are: (1) endemic outflow 
of capital from core regions, (2) international competition, 
particularly from Japan and newly industrializing countries, 
(3) stagflation, which is reflected in declining industrial 
productivity, rising unemployment, and the fiscal inability to 
maintain huge public expenditures to keep the Keynesian 
welfare state in operation. Hence: 
(a) production systems are displaying signs of a 
deepening di vision of labor and an expansion of 
external economies of scale, (b) that local labor 
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markets are becoming increasingly less rigid in 
structure, and (c) that rapid reagglomeration of 
production has been occurring as a consequence 
(Scott, 1988:185). 
Scott's analysis sheds light on the relationship between 
flexible production and regional development and enhances 
further investigation of policy implications for this new form 
of organization. More specifically, he hypothesizes that 
flexibility will be found in three industrial sectors: 
revivified artisanal and design-intensive industries; high 
technology industries and their associated phalanxes; and 
services, mostly business services. 
Almost at the same time, Sabel (1988) shared Scott's view 
of the emergence of flexible production regions. He asserted 
that the move toward more and more flexible responses may lead 
to the reconsolidation of the region as an integrated unit of 
production. However, he took one step further to discuss 
potential problems with this new form of production. He 
believed that even if regional economies do emerge, they will 
find it difficult to survive without the aid of national 
institutions. Flexible firms may be better able to survive the 
poor economy than those of mass production. However, it does 
not necessarily mean that they will be immune from failure. 
Regions lagging behind still need assistance from the 
prosperous areas, and a new national resource allocation 
system would be needed to achieve that. 
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1.4 Flexibility and the Labor Process 
A second area of discussion is the relationship between 
flexibility and the labor process. Schoenberger (1988) 
asserted that while there may be gains in job security and 
union relations as flexibility requires more participation of 
workers, flexible specialization demands extremely flexible 
work schedules, for example, part-time work will rise with the 
requirements of increasing flexibility. 
Harvey (1989) argues that flexibility rests on the labor 
process and it has led to the radical restructuring of the 
labor market. He states: 
"Faced with strong market volatility, heightened 
competition, and narrowing prof it margins, 
employers have taken advantage of weakened union 
power and the pools of surplus (unemployed or 
underemployed) laborers to push for much more 
flexible work regimes and labor contracts" (Harvey, 
1989:150) 
Under this circumstance, the labor market takes on a 
core-periphery pattern as portrayed in Figure 1.1. "The 
core... is made up of employees with full time, permanent 
status and is central to the long term future of the 
organization'" (Harvey, 1989:150). It is a relatively small 
group. However, the periphery includes two rather different 
sub-groups. 
"The first consists of full-time employees with 
skills that are readily available in the labor 
market, such as clerical, secretarial, routine and 
lesser skilled manual workers. With less access to 
career opportunities, this group tends to be 
characterized by high labor turnover .... The second 
periphery group 'provides even greater numerical 
flexibility and includes part-timers, casuals, 
6 
FIRST PERIPHERAL GROUP 
SECONDARY LABOUR MARKET 
NUMERICAL FLEXIBILITY 
CORE GROUP 
PRIMARY LABOUR MARKET 
FUNCTIONAL FLEXIBILITY 
Figure 1.1 Labor Market Structures under Conditions of 
Flexible Accumulation 
Source: Harvey, D (1989:150) 
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fixed term contract staff, temporaries, sub-
contractors and public subsidy trainees, with even 
less job security that the first peripheral 
group."' (Harvey, 1989:150). 
This new form of labor organization makes collective 
action more difficult since it fosters extreme individualism. 
Harvey's analysis opens another channel for looking at 
flexibility. 
1.5 Critiques of the Flexible Specialization Thesis 
A number of critical questions have been raised 
regarding flexible specialization. These criticisms center 
around three issues; 
1. Phenomenon or Essence 
Storper (1989) questions the existence of a new regime of 
flexibility. 1 He asserts that much flexible production is 
nothing more than specific technological and organization 
strategies. Although flexible specialization appears to be 
spreading, there are still many mass producers in operation. 
Therefore, a deeper study regarding this new form of 
capitalist production should be done to examine the underlying 
logic of recent socioeconomic change. 
1 Storper basically raises the question of whether flexible 
production is, in fact, just a manifestation of the "phenomenon" or 
instead, the essence of "nature". 
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2. Fordism is still alive 
Sayer (1987) argues that Japan should receive more 
attention and that fordism is still alive. He does so on four 
grounds. First, even if one accepts that postwar capitalism is 
fordist and that capitalism is currently in crisis, we cannot 
logically deduce that fordism is therefore in crisis because 
fordism is not necessarily the cause of capitalism's 
crises. 
Second, some alleged inherent limitations of fordism are 
really not limitations. Fordism did not create improved 
working conditions so that labor resistance builds up. 
Notwithstanding "labor resistance did build up in a few 
fordist sectors, particularly the car industry, but less so in 
others, and no more so than in many nonf ordist sectors" 
(Sayer, 1987:669). Also, Japanese mass production has not 
failed. The evidence that the rate of productivity change in 
mass production is declining in fordist sectors is 
inconclusive. 
Third, many current problems have nothing to do with the 
labor process, but with the relative lack of new sectors or 
products. Fordism might still flourish if technological 
innovation is successful. 
Fourth, if small-batch production is still resistant to 
automation and rapid increases in productivity, the crisis of 
small-batch production rather than the mass production sector 
could be at the root of the current crisis. 
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3. The question of space 
Amin (1989) argues that the flexibility debate treats 
space in a partial and uni-directional, evolutionary way. The 
assumption of: 
"spatial agglomeration and the local containment of 
the functional division of labor best respond to 
the organizational demands of flexible 
specialization .... (this) underplays the existence 
of significant differences in the characteristics 
and origins of various contemporary industrial 
districts, such as the importance of large 
retailers and subcontractors as key actors in some 
areas, or sma 11 firms networks in other areas" 
(Amin , 198 9 : 18 ) . 
Amin depicts FS's uni-directional evolution as counter 
historical. He mentioned: 
"Accurate or not, this approach nonetheless ends up 
treating the modern local industrial complex as a 
point of arrival, paying little attention to the 
forces which are likely to reshape or even threaten 
their contemporary evolutionary status" (Amin, 
1989:18). 
1.6 Flexibility and the Medical Instruments and Supply 
Industry 
The two most often cited proximate causes of 
flexibility's growing importance are technology and economic 
instability (Feldman, 1989b: 12). New technologies have greatly 
reduced the cost of flexible production processes and hence 
have made entirely new flexible production systems possible 
(Scott 1988, Feldman, 1989b). Moreover, Scott (1988) stated 
that the new regime of flexible specialization is founded in 
three major industrial sector. One of them is the high 
technology or "leading edge" industries. Economic instability 
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caused mainly by intensified international competition has 
made the large and stable markets mass production needs to 
achieve economies of scale hardly exist (Piere & Sabel, 1984, 
Scott, 1988, Feldman, 1989b). Therefore, firms adopt flexible 
production methods that allow them to respond quickly to 
changing economic situations. 
The American medical supply industry has been considered 
as the global leader in the production of medical instruments 
and supplies due to its continuous and ambitious development 
of new, high-tech, sophisticated equipment. New technology 
has played a significant role in the development of the 
industry (S&P, 1986, 1987, 1988, 1990, 1991). On the other 
hand, the industry also faced more and more intensive 
international competition from Japan, Germany, West European 
countries and other newly industrialized countries since these 
countries have also launched huge R&D programs in the 
development of high-tech medical devices. Obviously, 
technology and international competition have strongly 
influenced the development of this industry. Studying the 
medical supply industry and its relationship with flexibility 
would certainly provide further understanding of flexibility 
and its causes and it, in turn, would enhance the whole 
academic debate. 
Furthermore, the study of medical supply industry and its 
relationship to the flexibility debate has practical merit. 
The medical supply industry has undergone substantial 
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development during the last two decades. It has maintained a 
double-digit average growth rate (12.85%) in industrial 
shipments, which has outpaced the growth of the manufacturing 
sector as a whole ( 7. 55%) (see Table 3. 4) . It also created 
many job opportunities, its average employment growth rate 
during last two decades has reached 5.33%, which also outpaces 
the growth of the manufacturing sector (0.45%) (also see Table 
3.4). Moreover, the industry is also considered as a trade-
surplus earner. During the last two decades or so, the trade-
surplus created by the industry has increased from $210 
million to $2,109 million, representing again a double-digit 
growth rate (13.67%) (see Table 3.2). 
The question is whether or not the strong performance of 
the medical supply industry is attributable to flexible 
specialization as the flexibility theory itself claims. 
Certainly, the answer to this question will help the 
development of other industries, as well as the medical supply 
industry itself, by helping key actors know better about their 
situation and adopt strategies appropriate for their 
industries' development. 
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Chapter Two 
Methodology 
Previous research on flexibility had the problem of 
overwhelmingly relying on case studies. However, little, if 
any systematic 
industries for 
selection process 
case studies. 
was 
This 
used to choose the 
research project, 
nonetheless, was derived from a systematic process. 
In the initial period of research, national data were 
collected and analyzed to identify industries in which 
flexibility seemed to be increasing. Data for the this period 
mainly came from Small Business Data Base (SBDB) of U.S. Small 
Business Administration from 1976-1984. A number of indicators 
were constructed which included the number of specialist 
independent establishments, employment per establishment, and 
total industry employment. Changes in these indicators were 
measured by using regression residuals method (analyzed at the 
four-digit SIC level) (Feldman & Yuan, 1990). The results of 
this analysis showed that several industries appeared to be 
becoming more flexible and vertically disintegrated. We choose 
three industries for in-depth study. These industries are: 
textile finishing, aircraft parts, and the medical instruments 
and supply industry. 
The second portion of the study involved analysis of 
secondary data related to the industry, face-to-face 
interviews with firms in the industry, and the study of 
related academic literature and case studies on the industry. 
13 
Secondary data included come from: The Annual Survey of 
Manufactures, The Census of Manufactures, Standard and Poor's 
Industrial Surveys, Moody's Industrial Manual, and The Wall 
Street Journal. 
Principals at five medical supply firms were interviewed. 
Questions related to the company's history, production 
process, location, and labor relation were asked. 
Finally, all this information was collected and analyzed 
to present a detailed study of the industry and its 
relationship to flexibility. They will be presented in Chapter 
5. It is intended to answer the question of whether or not 
flexibility is occurring in the medical supply industry. 
14 
Chapter Three 
Historical Development of the Medical Instrument and supply 
Industry 
3.1 The Medical Instrument and Supply Industry 
The medical instrument and supply industry (hereafter 
referred to the medical supply industry) in this study, refers 
to the category of "Surgical, Medical, and Dental Instruments 
and Supplies" defined by the 1987 Standard Industry 
Classification Manual (USOMB,1987:250-252) to include the 
following 4-digi t SIC codes: 2 (Definitions 
categories are given in Table 3.1.) 
SIC 3841: Surgical and Medical Instruments 
SIC 3842: Surgical Appliances and Supplies 
SIC 3843: Dental Equipment and Supplies 
SIC 3844: X-Ray Apparatus and Tubes 
SIC 3845: Electromedical Equipments 
for these 
3.2 Factors Affecting the Development of the Industry 
The medical supply industry has been influenced by 
factors such as technology, government regulations, foreign 
trade and competition, and other factors like demography, 
litigation, and the incidence of new diseases. Each of these 
factors are discussed below. 
2SIC 3844 and SIC 3845 did not exist until 1987. 
Therefore, to perform a consistent analysis of the medical 
supply industry, SIC 3693 (X-Ray, Electromedical, and 
Electrotherapeutic Apparatus) is used instead of SIC 3844 and 
SIC 3845 for the period before 1987. After 1987, SIC 3693 was 
divided into SIC 3844 and SIC 3845. SIC 3693 ceased to exist. 
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SIC 
3841 
3842 
3843 
3844 
3845 
Table 3.1 
Definition of the Medical Supply Industry 
Definition 
Manufacturing medical, surgical, ophthalmic, & 
veterinary instruments & apparatus. 
Manufacturing orthopedic, prosthetic, and 
surgical appliances & supplies, arch supports 
& other foot appliances, fracture appliances, 
elastic hosiery, abdominal supporters, braces, 
& trusses, bandages; surgical gauze & 
dressings, sutures; adhesive tapes & medicated 
plasters; & personal safety appliances & 
equipments. 
Manufacturing artificial teeth, dental metals, 
alloys, & amalgam, & a wide variety of 
equipment, instruments, & supplies used by 
dentists, dental laboratories and dental 
colleges. 
Manufacturing radiographic X-ray, fluoroscopic 
X-ray, & therapeutic X-ray apparatus & tubes 
for medical, industrial, research, & control 
applications, or in manufacturing other 
irradiation equipment including gamma & beta 
ray equipment. 
Manufacturing electro-medical & electro 
therapeutic apparatus. 
Source: US Office of Management & Budget (1987:250-252). 
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3.2.1 Technology 
The development of the medical instrument and supply 
industry has been enhanced historically by the development of 
technology. As stated by Malecki: 
"The development of instruments for chemical 
analysis of blood pressure and urine was fairly 
well advanced by the 1800s. But it was not until 
the 1950s that laboratory tests became automated, 
prompting a vast expansion of diagnostic 
testing. 11 (1985:353) 
During the same period, machines for continuously 
monitoring body functions such as blood pressure were being 
developed (Malecki, 1985:353). This industry has been affected 
by the recent development of ultrasonic equipment, 
hemodialysis apparatus, utilization of plastic products, and 
inhalation therapy equipment. High-tech products, including 
premixed drug solutions, continuous ambulatory peritoneal 
dialysis (CAPO), enteral nutritional feeding systems, cardiac 
angioplasty, and similar devices, also spurred the growth of 
medical supply industry (S&P, 1991:H36). State-of-the-art 
high-tech products, such as magnetic resonance imaging (MRI) 
equipment, magnetic source imaging (MS!), digital medical-
picture arching and communications systems (PACS) I 
ventricular-assist devices (VADs) and implantable 
defibrillators are expected to greatly strengthen the industry 
in the near future (S&P, 1991:H37-H39). The enhancement of 
medical technology will continue to strive for safer products 
which are both medically and cost effective. 
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3.2.2 Government Regulations 
Government regulations have always played a significant 
role in the medical instruments and supply industry because of 
the industry's unique features. The effects of these 
regulations are two-fold. First, these regulations were 
generally introduced to require manufacturers of medical 
devices to produce safer, more medically effective, and cost 
effective products. To fulfill the requirements of these 
regulations, manufacturers of medical devices and suppliers 
have to increase the cost of developing and marketing new 
products. Second, it lengthens the time required for the 
introduction of new products. During the late 1970s and 1980s, 
three pieces of government regulation created a profound 
impact on the medical supply industry and will continue to 
impact it in the foreseeable future. They are the Prospective 
Payment System (PPS), the Safe Medical Device Act (SMDA) and 
Good Manufacturing Practice for Medical Devices (GMP). 
In response to the explosive growth of medical 
expenditures, the Federal government, in 1983, introduced the 
Prospective Payment System (PPS) which establishes cost 
ceilings for Medicare and Medicaid inpatient treatment (USDC, 
1990:51-1). In other words, it reimburses hospitals for 
Medicare and Medicaid patients at pre-set rates. As a result 
of this cost-containment mechanism, hospitals have to curtail 
their costs through centralized and standardized purchasing, 
competitive bidding, and the formation of group purchasing 
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organizations (USDC, 1986b:34-1). These have created intense 
pricing pressures on medical device suppliers. In view of 
these facts, the medical supply industry has responded by 
developing products that shorten the length of stay through 
better diagnostic methods and treatment procedures. Also, the 
industry invests in creating products that improve labor 
productivity or reduce labor costs. Moreover, the industry has 
responded by carefully looking at new and rapidly growing 
markets not covered by PPS such as freestanding ambulatory 
care centers, outpatient diagnostic centers, and home health-
care agencies (USDC, 1986b:34-1). 
Initiated by Representatives Henry Waxman (D-Calif.) and 
John Dingell (D-Mich.) in 1989, the Safe Medical Device Act 
(SMDA) was passed by Congress and signed into law by President 
Bush in late 1990 (S&P, 1991:H35). The SMDA requires higher 
standards of safety for medical devices. This new legislation 
is intended to replace the old 510(k) approval system (the 
1976 Medical Device Amendment) with a more stringent product 
pre-marketing approval (PPA) process. 
Under the old 510(k) approval system, only manufacturers 
were held responsible for reporting serious injuries or deaths 
from the operations of their products, whereas under the new 
law, these reports are also required from hospitals, clinics, 
and other end users (S&P, 1991:H35). Moreover, this new bill 
requires user facilities to report deaths, serious injuries, 
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or illnesses associated with such devices to the FDA and/or to 
the manufacturer within 10 days of occurrence. 
Ninety percent of all medical devices that are presently 
cleared for sale under 510(k) system, are approved within 90 
days. Under the new legislation, this review and approval 
system could take more than a year. Moreover, this new law 
requires post-market surveillance by any manufacturer of new 
implantable products whose malfunctioning could cause serious 
health problems. 
SMDA will also impact the imposition of time limitations 
on patent rights for new medical devices. For example, SMDA 
provides that one year after the approval of four similar 
devices, the FDA may use the data in one producer's product 
pre-market approval for other purposes, including background 
information to grant approval for a competitor's product (S&P, 
1991:H36). 
The medical supply industry has opposed this new bill, 
claiming that the more complex and time consuming review 
system would retard the pace of new product innovation and 
lead to higher costs of medical equipment (S&P, 1990:H33). 
This has also led to the rise of the industry's investment in 
R&D to develop advanced and cost-effective products for the 
market (S&P, 1990, 1991). 
The good manufacturing practice for medical devices (GMP) 
was introduced in 1978 by the Federal government. It is 
intended to assure that medical devices will be safe and 
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effective for human use. The regulation set forth the 
requirement for the production of medical devices in the 
different periods of the production process, from 
manufacturing, packing, storage and the final installation of 
all devices. The main purpose of the regulation is to control 
quality. It stipulates every finished medical device 
manufacturer should prepare and implement a quality assurance 
program in its production process. 
The impact of this regulation on the medical supply 
industry are basically two-fold. First, it creates a special 
relationship between suppliers and manufacturers. On the one 
hand, suppliers have to meet strict requirements for 
manufacturers' acceptance of their products. On the other 
hand, once suppliers have fulfilled manufacturers' 
requirements, they become relatively advantaged in staying the 
market since other competitors have to meet the requirements 
first. In other words, these "approved" suppliers are in a 
relative safe position. This may lead to the continued 
successful performances of some small and medium suppliers 
while others fall by the wayside. 
Secondly, it helps firms in the medical supply industry 
build their reputations. Once production is implemented 
through GMP, a certain level of quality is assumed. This helps 
manufacturers stay in and further penetrate both domestic and 
international markets. 
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3.2.3 Foreign Trade and Foreign Competition 
Foreign trade has always played a very important role in 
the medical supply industry. Table 3. 2 contains data on 
exports and imports in the industry for the years 1972 through 
1990. During this period, the medical supply industry's 
exports have always exceeded its imports. This has resulted an 
increase of trade surplus from $210 million to $2,109 million, 
representing an average growth rate of 13.67%. According to 
the estimate of the US Department of Commerce, exports in the 
medical supply industry are expected to rise 12% to $6. 5 
billion in 1991. With imports expected to increase 9.1%, to 
$3.6 billion, the trade surplus would amount to about $2.9 
billion in 1991 (USDC, 1991a:H36). 
The fact that the medical supply industry has performed 
extremely well in foreign trade is attributable to the 
following factors. First, the US is recognized as the global 
leader in the production of medical instrument and supplies 
due to its continuous development o~ new and sophisticated 
equipment. Second, foreign governments are increasing emphasis 
on providing quality health care services, and third, the 
lower value of the US dollar compared to most major world 
currencies has made US products cost-competitive. 
However, the strengthening of the dollar combined with 
intensified 
manufacturers, 
products, is 
competition from 
especially in 
expected to result 
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Table3.2 
Trade Data for IM Medical Supply lnduolty 1972-1990 
(in millions o( dollan) 
1976 
223 
199 
24 
.'60 
8'>.5 
27.\5 
159 
40.Z 
118.8 
84.5 
! .' 
bl.5 
1977 
3.18 
2~~ 
103 
401 
9! 
J09 
178 
59 
119 
9' 
.10 
b! 
1978 
S39 
239 
300 
36S 
126 
2J9 
226 
69 
1.17 
79 
45 
34 
1979 
717 
215 
442 
410 
146 
!64 
258 
!OS 
IB 
IOI 
4l 
59 
1980 
837 
312 
S2.S 
485 
174 
311 
309 
94 
215 
117 
41 
R6 
1981 
10'.IO 
380 
670 
570 
20'.'i 
365 
.165 
95 
270 
140 
50 
90 
1982 
102.S 
487 
S38 
60S 
222 
383 
37S 
108 
267 
143 
49.9 
93. I 
1983 
1086 
673 
413 
519 
2S8 
321 
402 
109 
29.1 
146 
S5.4 
90.1> 
ValueolF.if"'rts .• .U . I 418.7 5R9.4 710 I R!b.5 1009 1!09 l4R6 1758 !1!5 2148 Z21.1 
Value oflmports l!J. I 17J !!1.! !9'11 .1 ·18.7 416 499 568 6!1 7.10 866.9 1095.4 
Exports· lmporu 210 245.7 .162.2 410.·I 477.8 W.1 710 918 11.17 1395 1281.1 1117.6 
Source : Compiled from US lnduslrial Oullook-Medical lnslrumenµ. US D<pl ol Commerce. Rur<au o( Census. 1982. 1986 and 1990. 
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277 
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466 
795 
-329 
1549 
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2638 
1157 
1481 
1990 
1601 
670 
931 
l<M2 
420 
622 
.\01 
143 
164 
508 
866 
-358 
1671 
921 
150 
l~ 
1233 
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growth in the years ahead (USDC, 1991a:H36). Moreover, Japan 
holds a considerable lead in the development of super-
conductivity, high definition television, and X-ray 
lithography. All of these areas will have an important bearing 
on the development of high-tech medical products, which will 
influence the performance of trade in the years ahead. 
Another growing concern is the European Community (EC) 
and its efforts to create a single internal market. While this 
new system may result in streamlined regulatory procedures and 
simplified marketing, it is also likely to encourage greater 
price competition (USDC, 1990:H33). 
Medical suppliers are also interested in Eastern Europe 
and the former Soviet Union (now CIS) due to their recent vast 
political changes. Although new markets in these countries 
seems to be appearing, competition from the former Soviet 
Union may occur if its sophisticated national defense system 
can be successfully transferred to civil usage. 
3.2.4 Other Factors 
Other factors like demography, litigation, newly 
diagnosed diseases such as AIDS and other infectious disease 
have also influenced development of the industry. The aging 
population of the us and other major trading partners (such as 
Japan and Western Europe) is stimulating the demand for 
quality medical products. According to the U.S. Census, the 
65-and-over age cohort accounted for about 12. 6% of the 
population in 1990, versus 11.2% in 1980. Estimates from the 
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Bureau of Census are that this segment of the population will 
rise to 21% of the nation's population by the year 2030 (USDC, 
1987b:H31). 
Litigation is also contributing to the growth of the 
industry, as doctors and other medical professional often use 
costly diagnostic tests to protect themselves from devastating 
malpractice claims (USDC, 199la:H35). The incidence of AIDS 
and other infectious disease has also resulted in increased 
demand for new diagnostic tests and other safeguards against 
these diseases. 
3.3 Value Added, Value of Shipments and Employment in the 
Industry 
The medical supply industry outpaced manufacturing as a 
whole in value added, employment, and value of shipments 
between 1963 and 1989, according to statistical records. 
Tables 3.3 and 3.4 reveal the historical development of the 
industry with regards to these three indicators. Value added 
grew from $721.3 million in 1963 to $17,622.9 million in 1989, 
which makes up an annual average growth rate (AAGR) of 13.08% 
that far outpaced the 7.66% AAGR of the manufacturing sector 
during the same period of time. The medical instrument and 
supply industry's share in manufacturing value added increased 
from 0.38% to 1.35% within the same time span. 
Employment increased from 57.6 thousand in 1963 to 222.4 
thousand in 1989, with an annual average growth rate of 5.33%. 
Again, this exceeds the manufacturing sectors AAGR of 0.45%. 
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Table 3.3 
The Medical Supply Industry in Manufacturing by Value Added, Employment & Value of Shipments 
(1963-1989) 
Value Added in Billions Emeloment in Millions Value of Shiemen1s in Millions 
Year Medi. Manu. %ofMedi. Medi. Manu. % of Medi. Medi. Manu. %ofMedi. 
in Manu. in Manu. in Manu. 
1963 0.72 192 0.38 0.06 17.00 0.34 1172.2 420528.l 0.28 
1964 0.74 206 0.36 0.06 17.30 0.33 1233.0 447985.l 0.28 
1965 0.83 227 0.37 0.06 18.00 0.35 1336.4 492005.7 0.27 
1966 0.96 251 0.38 O.o7 19.10 0.37 1557.0 538736.9 0.29 
1967 1.10 262 0.42 0.08 19.30 0.39 1767.0 557397.8 0.32 
1968 1.31 285 0.46 0.08 19.60 0.42 2078.8 603220.l 0.34 
1969 1.48 306 0.48 0.09 20.00 0.45 2348.6 642635.8 0.37 
1970 1.48 300 0.49 0.09 19.20 0.45 2339.8 634322.1 0.37 
1971 1.74 314 0.55 0.09 18.40 0.48 2651.7 670970.5 0.40 
1972 2.13 354 0.60 0.10 19.00 0.54 3268.2 756534.3 0.43 
1973 2.35 404 0.58 0.11 19.90 0.54 3638.l 875443.2 0.42 
1974 2.75 452 0.61 0.12 19.80 0.61 4449.4 1017873.4 0.44 
1975 3.14 442 0.71 0.13 18.30 0.69 5114.9 1039377.4 0.49 
"" 
1976 3.47 511 0.68 0.13 18.80 0.69 5712.6 1185695.3 0.48 
CJ'I 1977 4.49 585 0.77 0.14 19.60 0.73 7089.0 1358526.4 0.52 
1978 4.95 657 0.75 0.16 20.50 0.76 7940.0 1522937.3 0.52 
1979 5.66 747 0.76 0.16 21.00 0.76 9124.7 1727214.6 0.53 
1980 6.28 774 0.81 0.17 20.60 0.82 10338.l 1852668.3 0.56 
1981 7.64 838 0.91 0.18 20.30 0.88 12409.0 2017542.5 0.62 
1982 9.71 824 1.18 0.19 19.10 0.99 15133.3 1960205.8 0.77 
1983 10.23 882 1.16 0.19 18.70 1.01 16069.9 2045853.3 0.79 
1984 11.70 984 1.19 0.20 19.10 1.03 18135.0 2253429.3 0.80 
1985 12.50 1000 1.25 0.20 18.80 1.06 19205.9 2280183.8 0.84 
1986 12.82 1035 1.24 0.20 18.40 1.08 19621.7 2260314.5 0.87 
1987 14.73 1167 1.26 0.20 18.90 1.08 22838.7 2475901.0 0.92 
1988 16.88 1262 1.34 0.21 19.15 1.10 25329.8 2682605.9 0.94 
1989 17.62 1308 1.35 0.22 19.04 1.16 27183.0 2793014.5 0.97 
Source: Calculated from the Census of Manufactures, 1977, 1982 and 1987; and The Annual Survey of Mapufactures 1984, 1986 and 1989. 
US Dept. of Coinmen:e, Bureau of Cell&UI. 
Table 3.4 
Comparison of the Medical Supply Industry and Manufacturing 
by Annual Average Growth Rate (1963-1989) in Percent 
Manu. 
Medical 
Value Added 
7.66 
13.08 
Employment 
0.45 
5.33 
Value of Shipments 
7.55 
12.85 
Source: Calculated from The Census of Manufactures, 1972, 1977, 
1982, and 1987 and The Annual Survey of Manufactures, 1984, 1986 and 1989. 
US Dept. of Commerce, Bureau of Census. 
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The share of manufacturing employment has also increased from 
0.34% in 1963 to 1.16% in 1989. 
The industry's value of shipments grew from $1,172.2 
million in 1963 to $27,183 million in 1989. It has resulted in 
an annual average growth rate of 12.85%. This rate surpassed 
the overall manufacturing growth rate of 7.55%. The share in 
total manufacturing value of shipments also increased from 
0.28% to 0.97%. 
The medical supply industry's pace of development is also 
evident in comparison with other instrument-related 
industries. Table 3.5 summarizes the comparison. The medical 
supply industry (SIC384) increased its share in SIC 38 
(instruments and related products) value added from 16.84% in 
1970 to 22.44% in 1989. Its position in all industries within 
SIC 38 has constantly remained in third place during the past 
three decades. With regard to employment, the medical supply 
industry boosted its share in SIC 38 from 19.17% in 1970 to 
22.99% in 1989, and has maintained its position in third 
place. Value of shipments, another indicator, also shows that 
the medical supply industry has grown at a considerable rate. 
Proportionally, SIC 38 increased from 18.75% in 1970 to 25.85% 
in 1989. Its ranking amongst all industries in SIC 38 slightly 
decreased from second to third place. 
In conclusion, the medical supply industry has undergone 
substantial growth during the last three decades. Its 
importance in manufacturing has also gradually increased. 
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Table 3.S 
Compariaon ol tlw Medial Supply lnd..tuy with ~r l<UtNmen1 lnd...uin by Value Added, Employmtnt" Value ol Sbipmenll 
'Ito( 'jl,o( 'jl,o( 
"'"' 
Rank 
Value Ad&d tn MiUion Oollan 
'""" '""" 
lot al lotal
lndusu"/SIC Code 19 70 l<JllO 1985 1989 1970 1970 1970 1970 1970 1980 198S 1989 
TotalSIC 38 7905.3 21913. I 40278.3 785-16.8 100.00 100.00 100.00 100.00 
rhotographic Equiprncnl " Suppl~· ( 386) 3187.3 9930.8 12ZS7.4 15~.? 40.3? 4S.32 30.43 20.12 
Me .. uring &. Con!rolhng Devices (38?) IHS.O 8127.8 I 1621.6 1n84.8 19.42 37.09 !8.8S 22.64 2 2 
Med1«1I Supply lndu11ry (384) 1331.6 4090.8 9?43.8 176?3.0 16.84 21.41 ??.9S 22.44 3 3 
S.arch &. Navigation Equipment (381) 7!S.3 18?1.3 ?.S81.0 23914.S 9.17 8.31 6.41 30.46 
Wa1eh<., Clock..s, &. Walch<:uft (387) 469.0 663.5 418.6 681.4 S.93 3.03 1.04 0.87 s 7 7 
Oph<halmic Goods (38S) 3S9.7 839.0 99S.6 IS4!.6 4.SS 3.83 2.47 1.96 6 6 6 
~1ical lns<rurncnu &. Len- (383) ?97.4 1839.8 3160.3 1186.3 3.7() 8.40 7.8S l.S I 7 4 4 6 
%o( %oC %of ljl,o( Rant Rank !Unk Rant 
Employmcnu in "Thous.ands lot al h>lal lot.al lotal 1n IO in in 
lnJu11!}:/SIC Code 1'170 l<;g(j llll!S 1969 1970 1970 1970 1970 1970 1980 198S 1989 
t-J Touil SIC38 401.6 616.4 600 967.5 100.00 100.00 100.00 100.00 
'° 
Me .. uring &. Con1r<>lhng Devices (382) 10.1.8 ?31.8 21 7.1 !o!.O ?5.6S 37.ol 35.93 27.otl 
l'h0<ographic Equ1pmc:n1 &. Suppl~ (3861 9! . ~ 114.2 '1115 87.0 2?.86 18.53 16.30 8.99 
Mcchc.ol Supply lndus<ry (384) 77.o 1!9.8 152.1 !!2.4 19.17 ll.06 ! S. 17 22.99 
S<an:h & Nav1ga1ion Equ1pcncnl (381) 50.5 44.7 46. 7 339.5 12.48 7.?S 7.73 35.09 4 4 
Wauh<s. Clock..s, and Wa<ct.c-s (387) .IS.O ?3.0 11 .8 10.S 8.oS 3.73 1.9S 1.09 s 7 
O ph1halmic Goods (38S) !7.1 ?9.4 ?4.9 !S.o 6. 70 4.77 4.1! 2.58 6 6 6 
O~i<al lnslrum<nlS & Lenses (383) 18.! 43.5 Sl.2 21.1 4.50 7.06 8.80 2.18 7 s 4 6 
<J. of %of %oC %of Rank Rank Rank Rank 
V aluc of Shipmc:nu tn Million Dollan lot al IOI al 101al lolal 1n in in in 
lnJusor;/SIC Code 1'170 1960 1'11\S 1969 1970 1970 1970 1970 1970 1980 198S 1989 
TolalSIC38 1178?.S 44138.7 61008.2 118486.1 100.00 100.00 100.00 100.00 
l'ho<ographic Equ1pmen1 & Suppl~ (386) 4413.S IS867.0 181 14 .4 22737.8 37.46 3S.95 29.69 19.19 
Measuring&. Con1rolling Devices (382) !!ol.9 12327.1 17479.9 ?7710.8 19.20 27.93 28.o5 23.39 
Medical Supply lndu1uy (384) !087.0 7809.4 14202.8 !7183.0 17.71 17.o9 23.?8 22.94 
S.arch &. Navigalion Equipm<nl (381) 1180.6 ?667.6 3933.9 .15?95.4 10.02 6.04 6.4S 29.79 
Wa1che1, Clock..s, and Walchcasc1 (387) 888.8 1511.0 912.I 1448.0 7.54 3.42 I.SO 1.22 s 6 6 
Ophlhalmic Goods (38S) 518.8 1211.9 1418.2 2193.S 4.40 2.15 2.32 I.SS 6 7 7 
0~1i<al lns<rurncnlS &. Len- (383) Hl.9 2744.0 4946.9 1917.S 3.67 6.22 8.11 1.62 7 4 4 6 
Souroc: Computed from lb< Annual Survey of Manufa<1ur<11 1970. 1980, 198S and 1989. US Dep1. of Commerce, Bureau ol Cen1ua. 
Compared with other instrument and supply industries, the 
medical supply industry performed very well. It has 
continuously outperformed other segments of the instrument 
industry and has maintained a strong, stable and higher 
ranking record compared to all instrument-related industries. 
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Chapter Four 
The Medical Supply Industry Today 
This chapter examines the current profile of the 
industry. It starts by looking at the industry's composition, 
followed by a discussion of the distribution of firms by size. 
Then, the focus shifts to the spatial distribution of the 
industry. Finally, brief descriptions of some leading 
companies in the industry are presented. 
4.1 The Industry Composition 
Table 4.1 summarizes the industry's composition. Surgical 
appliances and supplies (SIC 3842), the industry's broadest 
and most di verse group, ranks first in its value added, 
employment and value of shipments. Surgical and medical 
instruments (SIC 3841) ranks second. These two industries 
together comprise more than 70% of the industry's shipments 
and employment. In other words, the medical supply industry is 
dominated mainly by surgical appliances and supplies (SIC 
3842) and surgical and medical instruments (SIC 3841). 
The industry is extremely diverse with regards to 
products. It includes more than three thousand companies 
producing more than 130,000 different products {S&P, 
1987:H30), ranging from basic gauze pads to complicated 
magnetic resonance imaging (MRI) equipment. The eight largest 
companies in the industry account for about two-fifths of 
industry shipments (S&P, 1987:H30). 
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Table 4.1 
Composition of the Medical Supply Industry 
by Value Added, Employment and Value of Shipments 
SIC CODE Value Added% of Employmen % of Value of Ship- %of 
million$ total thousands total ment million $ total 
3841 6,059.8 34.4 83.9 37.7 8,971.6 33.0 
3842 6,504.4 36.9 84.4 37.9 10,187.1 37.5 
3843 851.9 4.8 12.9 5.8 1,277.1 4.7 
3844 1,113.6 6.3 9.4 4.2 1,925.8 7.1 
3845 3,093.2 17.6 31.8 14.3 4,821.4 17.7 
Total 17,622.9 100.0 222.4 100.0 27,183.0 100.0 
Source: Computed from The Annual Surve~ of Manufactures, 1989 
US Dept. of Commerce, Bureau of Census. 
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line of human health care products and services. These are 
divided into two groups: (1) pharmaceutical and nutritional 
products and (2) hospital and laboratory products. 
Pharmaceutical and nutritional products include adult and 
pediatric pharmaceuticals, nutritionals, and vitamins, which 
are sold primarily by prescription or the recommendation of 
physicians or other health care professionals. It comprised 
51.3% of 1990 company's sales (S&P, 1991:H37). It also 
includes personal care products, agricultural and chemical 
products, and bulk pharmaceuticals. 
Abbot's hospital and laboratory products include 
diagnostic systems for blood banks, hospital and clinical 
laboratories, and alternate care testing sites; intravenous 
and irrigating fluids and related administration equipment; 
venipuncture products; anesthetics, critical care equipment; 
and other specialty products for hospitals, clinical 
laboratories, and alternate care sites. It accounted for 48.7% 
of the company's sales in 1990 (S%P, 1991:H37}. 
4.4.3 Baxter International Inc. 
This company was originally incorporated in 1931 as 
Baxter Laboratories Incorporated. It was renamed Baxter 
Travenol Laboratories Inc. in 197 6 and adopted its present 
name in 1987. In 1989, it ranked third in the industry with 
$446 million net income (S&P, 1990:H46}. By 1990 it had 64,600 
employees. Eighty two point twenty seven percent of its total 
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sales and 49.17% of its operating income came from US 
operations. 
The company is engaged in the worldwide development, 
manufacture and distribution of a diversified line of 
products, systems and services used primarily in the health 
care field. It is further divided into four groups: hospital 
products and services, medical systems and specialties, 
alternate site products and services, and industrial products. 
Hospital products and services include a broad range of 
products for hospitals and clinical laboratories, such as 
products for intravenous therapy, products for administering 
intravenous solutions, specialty labware, diagnostic and 
microbiological instrumentation, and reagent systems and 
supplies. Medical systems and specialties include a variety of 
specialized medical products used for patient care, blood 
therapy, diagnostic purposes and cardiac care. 
Alternate site products and services include a broad 
range of supplies, equipment and services for home patients 
and alternate-site providers. Industrial products include 
products for educational 
industrial research and 
manufacturing facilities. 
4.4 . 4 Becton Dickinson & co. 
and government laboratories, 
development facilities and 
Originally incorporated in New Jersey in 1906, this 
company expanded to 18,500 employees and 6,854 stockholders by 
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1990. In 1989, its net income ranked fourth ($158 millions) 
among all establishments in the industry (S&P, 1990:H46). 
The company is engaged in two major health care segments: 
medical and diagnostic. Medical products include disposable 
and reusable hypodermic equipment, intravenous supplies, 
operating room products, cardiovascular devices, suction 
products, elastic support products, surgical blades, 
thermometers, examination gloves and contract packaging 
services. Medical products occupied 57.4% of the company's 
sales in 1990 {S&P, 1991:H37). Diagnostic products include 
blood 
manual 
collection products, laboratory ware and 
and instrumented microbiology products, 
supplies, 
hematology 
including instruments and other diagnostic systems, 
immunodiagnostic test kits and instrumentation 
Diagnostic products contributed the balance (42.6%) 
company's sales {S&P, 1991:H37). 
4.4.5 Bausch & Lomb Inc. 
systems. 
of the 
Incorporated in 1908 in New York, this company had 
expanded to 13,000 employees and 6,900 stockholders by 1990. 
Its net income ranked fifth ($114.4 millions) among all 
establishments of the industry in 1989 (S&P, 1990:H46). The 
company develops, manufactures, and markets health care and 
optical products, with major product lines in the personal 
health, medical, biomedical and optics fields. 
Health care products include personal health, medical and 
biomedical products. In the personal health area, major lines 
43 
are: solutions for the care of contacts lenses and the relief 
of eye irritation, contact lens accessories, certain over-the-
counter pharmaceutical products, home plaque removal devices 
and other oral care products. Medical products include contact 
lenses and lens materials, prescription pharmaceuticals, 
periodontal charting and exam systems, healing aids and 
healing diagnostic systems. Biomedical products include 
purpose-bred laboratory animals for biomedical research and a 
variety of biotechnical and professional services provided to 
the scientific research community. Optical products include 
sunglasses, ophthalmic frames, binoculars, rifle scopes, 
telescopes and optical thin film coatings. 
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Chapter Five 
Flexibility in the Medical Instrument and Supply Industry 
This chapter addresses the issue of "whether or not the 
industry is becoming more flexible and, if so, how?". The 
discussion starts by examining the strategies adopted in the 
industry in general when it is influenced by many different 
factors. Following that, the interviews conducted for this 
research are discussed. Third, some national characteristics 
of the medical supply industry are presented. Finally, in 
light of these primary and secondary data, the question of 
flexibility is addressed head-on. 
5.1 Strategies Adopted by the Industry in General 
During the past two decades or so, especially in the last 
10 years, the medical supply industry has faced different 
challenges. As discussed in Chapter 3, factors like changes in 
technology, intensive government regulation, foreign 
competition, and aging demography have played significant 
roles in the development of the medical supply industry. This 
section focuses on the industry's response to these changes, 
as well as the strategies it has adopted to cope with these 
challenges. 
5.1.1 Improving and Advancing Technology to Reduce Costs 
Under the influence of the 1983 Prospective Payment 
System (PPS), cost-saving has risen as an importance concern 
for the medical supply industry. PPS establishes cost ceilings 
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for Medicare and Medicaid patients, resulting in hospitals and 
other buyers of medical devices and suppliers being pressured 
to hold down costs. The industry's strategies aim at improving 
and advancing technology to produce equipment that can reduce 
labor cost, increase labor productivity, reduce hospital stay 
of patients, or facilitate patient care in less expensive 
environments. 
Early examples 
enhanced diagnostic 
handicapped persons, 
of these products include computer-
imaging systems, sensory aids for 
implanted prosthetic devices, patient 
monitoring systems, automated clinical analytical laboratory 
analysis units, and computer-based medical information systems 
(USDC, 1982b:277). Many of these products raise productivity 
in the delivery of health-care services thereby reducing the 
unit cost (USDC, 1982b). 
Examples of recent products that have fostered efficiency 
include ultrasonic, radiologic, and magnetic resonance imaging 
devices that show clear pictures of internal organs in three 
dimensions; patient monitoring systems that, in seconds, 
provide physiological parameters of the critically ill; and 
devices that crush kidney stones (USDC, 1986b: 34-1). These 
complex, technology-intensive, devices are relatively easy to 
use because of built-in features for operation, safety, self-
calibration, fault diagnosis, and repair. Hence, they 
increases labor productivity and reduces unit costs. 
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The most up-to-date technological advances that have 
boosted efficiency include increased use of premixed drug 
solutions, which has reduced hospital pharmacy costs; 
continuous ambulatory peritoneal dialysis (CAPO), instead of 
the more costly in-hospital hemodialysis for patients with 
kidney failure; enteral nutritional feeding systems which have 
been substituted for in-patient parenteral (intravenous) 
feeding; lasers for ophthalmological, dermatological, and 
various other surgical applications; and cardiac angioplasty, 
which is a cost-effective alternative to bypass surgery for 
treating arteriosclerosis in coronary arteries (S&P, 1986:H30, 
1991:H36). 
Another rapidly expanding market is laparoscopic, or 
endoscopic, surgical instruments. Laparoscopic surgery is 
accomplished by making a tiny hole through which to insert the 
laparoscope into a patient's body, instead of the six to eight 
inch incision necessitated by conventional surgical 
procedures. Because this procedure is less invasive and less 
traumatic to the patient, it typically involves much less pain 
and recovery time and results in substantial cost savings 
(S&P, 1991:H37). Johnson & Johnson recently launched a major 
campaign to move aggressively in the laparoscopic market. 
Through its Ethicon subsidiary, J&J introduced a full line of 
disposable laparoscopic instruments and stated its commitment 
to become the market leader in this fast growing field (S&P, 
1991:H37). 
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5.1.2 Penetrating into Drug Production 
Firms in the industry also moved into drug production, 
which is characterized by a growing market and relative lack 
of control from government. By aligning with traditional drug 
producers, the medical supply industry has initiated ambitious 
research and development programs, which have created 
successfully innovative, high-technology products. Traditional 
company, like J&J has expanded their presence in the 
pharmaceutical business in recent years and continue to invest 
heavily in new drug research and development (S&P, 1991:H36). 
In 1990, J&J's sale of pharmaceuticals accounted for 33.1% of 
company sales (S&P, 1991:H37) as compared to 21.2% in 1984 
(S&P, 1986:H29). 
The effort also extends to the international level. To 
cite one example, Baxter International and American Cyanamid 
formed a partnership with Quadra Logic Technologies of 
Vancouver, British Columbia to develop photodynamic drugs to 
help fight cancers (WSJ, 1990a). 
5.1.3 Offering Long-Term Contracts to Maintain Market Share 
Hospitals and other heal th-care providers have sought 
significant price discounts on medical products under the 
severe budgetary constraints imposed by PPS4 • Medical 
suppliers have offered long-term contracts at competitive 
prices with major buyers to lock up business. For example, 
4In 1989, 52% of sales of medical products in the US were 
from hospitals, which are subject to PPS (S&P, 1991:H35). 
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Abbott Laboratories cut prices on intravenous (IV) equipment 
by about 30% in a major, five-year contract with the Voluntary 
Hospitals of America to maintain market share in a shrinking 
business (S&P, 1990:H35). Baxter International also reached a 
five-year supply and service agreement with Mercy National 
Purchasing Inc. The agreement mainly involves medical and 
surgical supplies and diagnostic equipment. Baxter's strategy 
is to seek a more comprehensive and closer supply and service 
relationship with buyers (WSJ, 1990b). 
5.1.4 Targeting Non-hospital Markets 
Under PPS, medical suppliers have responded by targeting 
non-hospital markets, such as independent physicians, home 
heal th-care agencies, and other providers of heal th care-
providers, which are not covered by PPS. By increasing sales 
to these non-hospital markets, the industry has maintained 
steady growth. 
5.1.5 Targeting Geriatric Markets 
Facing the "Graying of America," as well as the fact that 
today's elderly5 tend to be nearly twice as wealthy as the 
general population (S&P, 1987:H31) and consume high amounts of 
medical products and services6 , the industry has targeted new 
technological products to serve the geriatric market. These 
5The Bureau of Census defines elderly as ages 65-and-
over. 
6About two-thirds of all medical products and services in 
the U.S are consumed by elderly persons (S&P, 1987:H32). 
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include items such as intraocular lens implants, non-invasive 
kidney stone removal instruments, cardiac valve prostheses, 
artificial sphincters for urinary control, incontinence 
products and organ transplants (S&P, 1987:H32). 
5.1.6 Exploring Foreign Markets 
Facing intensive regulation domestically, the industry 
has made efforts to explore international markets. Mechanisms 
include selling old patents to international firms, purchasing 
foreign companies, and undertaking intensive international 
marketing strategies. J&J reported allowing England's largest 
patent manager, British Technology Group to market its patents 
overseas. This strategy of selling licenses for its medical-
imaging technology products such as radiography, ultrasound, 
and computer tomography was an attempt to earn some extra 
revenue from old J&J patents (WSJ, 1989). GE purchased a 
French diagnostic imaging equipment maker, Thomson-CGR, the 
medical equipment division of an electronic manufacturer, so 
that GE would have a stronger position in the European and 
Latin American market (WSJ, 1987). Bausch & Laumb created an 
international division aimed at marketing its products (WSJ, 
1990c). American Hospital Supply merged with Baxter Travenol 
in 1986 so that American Hospital Supply could have access to 
Baxter's huge international marketing system while Baxter 
could make use of America's extensive domestic distribution 
system (S&P, 1986:H30). 
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5.2 Results of Industry Interviews 
To further understand the industry, representatives from 
five medical supply companies in New England were interviewed. 
Each company was asked questions about company history, 
location, the production process, and labor. To maintain 
confidentiality, company names are represented by the letters 
A, B, C, D, and E. 
5.2.1 Company History 
Company A was founded by a British company in 1948. The 
present owner has owned it since 1960. It operated in 
Providence for 3 O years and in Northern, RI its current 
location, for four years. The company basically manufactures 
custom needles, most of which are reusable. The current site 
is also its only manufacturing facility. 
Company B was founded in a small town near Boston, MA, 
where it still operates, in 1932. It is a family-owned 
business, currently in its fourth generation of family 
management. The company produces mainly disposable and 
veterinary needles, but also produces different types of 
needles as required by customer orders. 
Company C has been located in southeastern, MA since 
1968, before it moved out from east Boston. The company 
manufactures products researched and developed by physicians. 
Company D has been located in the same town as B since 
1971. Its main products include osmometers and other testing 
instruments such as those used to test dairy products. 
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Company E was started in the immediate Boston area 152 
years ago. It was bought by a major international firm and 
moved to its current location, southeastern, MA, in 1965. The 
current site is basically for research, marketing and other 
administrative activities. The 
activities are in an older 
company's 
industrial 
manufacturing 
city also in 
southeastern, MA. The firm is one of the world leaders in the 
production of surgical instruments. 
5.2.2 Location 
Although the current site has easy access to the 
airport, inter-state highway, and a good labor market, 
company A moved to its current location principally because of 
its new facility and improved building conditions. In other 
words, location was not a very critical factor in relocating 
this firm. The owner would have moved to any other place as 
long as a suitable building was available. 
Company B's current location is an historical legacy 
since it was started as a family business at its current site 
and continues to operate there. The present manager mentioned 
that the site enjoys the advantages of inexpensive space and 
availability of labor .. 
Company c has a different story regarding its location. 
It moved out from east Boston to its current site because of 
a rash of break-ins by drug addicts at the old location. It 
relocated to its current facility to avoid further break-ins 
and to take advantage of its proximity to Boston. However, 
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since the state has taken away many incentives for businesses 
to operate here, the manager said the company would choose to 
go elsewhere if it were to relocate now. 
Managers from Company D stated that, "location is largely 
irrelevant." While the company does enjoy the advantage of 
easy highway access for the employees, it need not be close to 
any suppliers or customers because of its small volume of 
shipments. All that is required is a place where there is UPS 
delivery and pick up and an easily accessible highway. 
However, managers mentioned that they would still locate here 
or within 10 miles of the current site since the highway 
system does provide convenience for employees to travel to and 
from work. 
The choice of location for Company E is a bit unique. The 
company has a site for non-manufacturing purposes and a site 
for manufacturing activities. The non-manufacturing site is 
located mainly for its proximity to Boston. The manufacturing 
site is located basically for its availability of labor force. 
Still, the sites are only about 20 miles apart. 
Most firms' managers told us location is largely 
irrelevant in their decision on where to locate because of the 
low volume of shipments. Reasons for current locations include 
historical legacies, new facilities, better building 
conditions, and avoiding break-ins. However, one thing the 
firms share in common is that the availability of good labor 
as a decisive factor in locating the company. Also, most firms 
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benefit from proximity to Boston so that they can take 
advantage of medical R&D in Boston. 
5.2.3 Production Process 
Company A's only function is manufacturing. Other 
decisions regarding management, marketing, accounting, 
banking, and other services are basically handled by the 
parent company in Long Island. The company produces customer 
needles, mostly reusable needles, and veterinarian 
thermometers. The production process is very much 
standardized, involving only simple machines. Batch production 
is the principal form of production in this company. The 
company has done very little sub-contracting to other firms 
since the batches are too small to make subcontracts 
economical. The company cannot afford to buy hi-tech, 
sophisticated machines since these machines require larger 
quantities of output to justify their costs. 
Company B is also involved in the production of needles. 
The production process requires simple, functional, and 
sometimes old fashioned machines. It is a small batch/job shop 
type of production. The company claims its success as a niche 
player. The company also produces various types of needles as 
requested by customers using the same machines. Labor skills 
are more important than machines in producing custom orders. 
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Company C involves production of equipment developed by 
doctors7 • It contains mass production of components and then 
assembly into specialized products. The company has received 
considerable assistance from a large medical supply company 
and has access to capital. The company has invested heavily in 
hi-tech machines, hoping that automation will enable it to 
"bump heads" with big firms and go into new markets. No sub-
contracting has been offered. 
Company D's production process is defined by the manager 
as "discontinuous batch processing." It mainly produces 
osmometers and testing devices for blood and dairy products. 
The whole production process is vertically integrated, 
involving basic technologies. However, the computer software 
and chemical tests are very much R&D intensive. 
Company E is one of the world leaders in the production 
of surgical instruments. According to its chief engineer, its 
plant is as modern as any surgical instrument plant in the 
world and production is totally vertically integrated. The 
company has its own research, marketing and sales departments. 
It heavily invests in hi-tech so that it will maintain its 
leadership role in the world medical instrument markets. It 
uses numerically controlled machines, computerized numerically 
controlled machines, computer-aided design, production cells, 
7We were not allowed to visit the workshop of the 
company, perhaps due to the company's concern over 
confidentiality of its products. All information was obtained 
through conversations with the CEO. 
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statistical process control systems, robots, and automated 
material handling devices. 
Although company E has made tremendous efforts to 
introduce new products and process innovations, three of five 
firms in our interviews still manufacture devices or equipment 
using old-fashioned methods. These firms still rely on simple 
and easy to operate machines, with new workers requiring 
little training. The firms are also characterized by the 
separation of management and production. Production workers 
are seldom involved in company policy. Most of the firms claim 
that they are vertically integrated and use batch production. 
In this sense, the whole process of production is done within 
that firm. Only a few firms have occasional sub-contracting 
when workloads are too high. 
However, even these firms do achieve some measure of 
flexibility through the use of unsophisticated machines to 
produce different products. Many small firms use this strategy 
to achieve their success as a niche player in an increasingly 
competitive market. 
5.2.4 Labor 
Company A currently employs about 50 full time and 2 part 
time workers (20 hours a week). However, the company prefers 
permanent workers and likes to hire individuals who want to 
make a career in this type of business. Therefore, ideal 
persons for them would be those in their late 20's to early 
30's, married and with children. It also wants new employees 
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who fit into the group and do not disrupt its harmony. New 
employees usually need 90 probation days and six months to one 
year's training. The wage scales range from $6.5 to $11 per 
hour. 
Company A is not unionized. The manager believes that 
this is very important for the company. He feels a union would 
not allow the company to move workers around to different 
tasks. Since the company requires workers to understand 
manufacturing process from beginning to end, it is a common 
practice for the workers to be fully interchangeable in 
different aspects of production. However, the company does not 
use flexible hours. The company has a solid labor force and 
its turnover rate is very low, with some employees having 
worked there for 30 years. 
Company B has about 30 employees. Most workers are older, 
retired people, with an average age of 64. The training period 
for new employees is basically 1 to 2 weeks. However, no 
formal training is undertaken. The company's labor strategy is 
to use cheap ($4.5 to $8 per hour), part time labor and to 
provide no health program for the employees so that it can 
reduce production costs and survive in its competitive 
environment. All employees are involved in production and 
quality control. The company allow great flexibility for 
workers to work from 15 to 35 hours per week. 
Company C employs 54 people. All employees are full time 
and about 50% are female. Training of new employees requires 
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about one year with the company using manual and video 
assisting tools as part of the training process. One of the 
company's large client helped set up the training program. 
Wage scales are relatively high, ranging from $7.50 to $18 per 
hour. Production workers also do quality control. Some 
rotation of jobs does occur. The company also uses a system of 
productivity targets for workers. This system is basically 
based on historical experience with specific products. When 
business is good, the company allows workers to work overtime. 
Company D currently employs 74 people, all full time 
workers. Occasionally, the company hires some temporary 
workers. Wage scales are very competitive, ranging from $10 to 
$15 per hour. The company requires no formal training for new 
employees. However, on-the-job training takes about 6 months. 
All workers must understand all procedures of production and 
be aware of quality control. The company also rotates the 
production workers between tasks so that every worker can do 
different tasks when necessary. 
Company E has 340 employees in its production site. Of 
them, roughly 60% are Portuguese and 40% are Spanish. The 
company offers above-average wages. The workers are non-
unionized and there is a very low labor turnover rate. The 
workers are responsible for quality control, and management 
encourages teamwork. The company estimates that the number of 
production workers will increase due to the expansion of the 
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company, development of new products, and the opening of new 
markets. 
The interviews uncovered that all five firms basically 
are satisfied with labor performance. Both management and 
labor wish to have a long time relationship. This is reflected 
by the willingness of the companies to hire permanent workers 
and the willingness of employees to stay with the companies, 
as evidenced by low labor turnover rates, with some workers 
remaining for 30 years. The wage scale in general is 
relatively stable with annual increases based on the company's 
performance. 
5.3 Specialization Ratio, Labor Turnover Rate and Change of 
Geographical Distribution of the Industry 
Historical data on specialization ratios8 collected from 
the Census of Manufactures are tabulated in Table 5.1. During 
the past two decades, the industry actually has slightly 
increased its specialization ratio. The most obvious example 
was SIC 3842 (surgical appliances and supplies) which 
increased its specialization ratio from 79 to 90 from 1972 to 
1987. This means that the industry in general has concentrated 
relatively more efforts on manufacturing products related to 
8The specialization ratio represents the ratio of primary 
product shipments to total product shipments (primary and 
secondary, excluding miscellaneous receipts) for the 
establishments classified in the industry (USDC, 1977:A-4). It 
is intended to measure how company specialize in their 
industry to which it claims to be belonged. However, 
limitation about this measurement exists. It can not measure 
how the company's flexibility through the use of same 
production technique to produce different products. 
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Table 5.1 
Specialization Ratio for the Medical Supply Industry 
SIC CODE 1972 1977 1982 1987 
3693 95 98 96 
3841 90 88 90 92 
3842 79 87 86 90 
3843 93 92 95 94 
3844 95 
3845 94 
Source: Computed from The Census of Manufactures, 1972, 1977, 
1982 and 1987, US Dept. of Commerce, Bureau of Census. 
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the medical instruments and supply. It seems to imply that 
while big firms are penetrating drug markets, certain 
proportion of the industry's companies still focus on the 
production of the medical products. 
The number of production workers by season in the 
industry are tabulated in Table 5.2. Between 1972 and 1987, 
seasonal variability in the number of production workers in 
the industry decreased. The coefficient of variation9 for the 
industry's seasonal employment dropped from 2.57 to 0.75 
during the period. 
Information on the change of the geographical 
distribution of medical supply industry with regard to 
establishments, number of employees, and value added is 
presented in Tables 5 . 3(a), 5 . 3(b) and 5.3(c). The West 
increased its share of establishments, from 24% in 1972 to 
28. 4% in 1987. Total employment increased from 14. 46% to 
29.62% during the same period, and value added increased from 
6.1% in 1977 to 22.1% in 1987. In contrast, the Northeast, 
North Central, and South regions have reduced shares in the 
national medical supply industry, judging from the number of 
9The coefficient of variation is calculated as the 
standard deviation divided by the mean and multiplied by 100. 
Therefore, it overcomes the weakness of standard deviation 
measure which does not take the magnitude of the variable into 
consideration. The coefficient of variation measures 
dispersion, in this case, the seasonal variability of the 
number of the production workers in the industry. However, 
this measurement does not take any business cycle, union 
policy and company policy into account, which all influence 
the seasonal variability of the number of production workers. 
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T.t.le S.2 
Number al Produclian Worter in tbe Medical Supply lnduotry ("' n.o...ndl) 
SIC 3693 1987 1982 1977 1972 
March 22.70 16.60 6.60 
W.y 22.90 16.90 6.80 
A&lpt 13.00 17.20 7.10 
~ 13.00 17.60 7.30 
Mean 22.90 17.08 6.9S 
SD 0.14 0.43 Q.31 
CV 0.61 2.52 4.46 
SIC3S41 
March 4S.60 3&.60 29.00 13.80 
M8y 45.20 31.90 29.00 2A.20 
Aupt 4S.20 3&.40 29.40 2A.30 
Nowmber 45.20 :'7.90 29.30 2.5.10 
Mean 45.30 3&.4S 29.18 2A.3.5 
so 0.20 0.42 0.20 Q.S4 
CV 0.44 t .09 0.69 2.22 
SIC 38-42 
March S0.20 47.00 36.00 29.00 
May S0.80 46.20 36.40 29.70 
Aupt S0.90 4S.80 36.90 30.00 
N011ember S2.30 4S.40 36.80 31.00 
Mean St.OS 46.10 36.S3 29.93 
SD 0.89 0.68 0.41 0.83 
CV t.74 1.48 1.12 2.77 
SIC3S43 
March 8.60 10.00 10. 70 8.30 
May 8.60 9.90 10. 70 L50 
Aupt a. 70 9.80 10.70 L50 
NOllember 8.80 9.40 to.SO 1.60 
Mean 1.68 9.78 10.65 8.48 
SD 0.10 0.26 0.10 0.12 
CV I.IS 2.66 0.94 1.42 
SIC3S44 1987 1982 1977 1972 
March S.40 
Maly S.50 
Aup>at S.40 
Nowmber S.40 
Mean 5.43 
SD o.os 
CV 0.92 
SIC 3S4S 
March 13.20 
May 13.10 
Aupt 13.10 
Nowmber 13.30 
Mean 13.18 
SD 0.10 
CV 0.76 
Total 
March 123.00 118.30 92.30 67.70 
Moy 123.20 117.90 93.00 611.20 
August 123.30 117.00 94.20 611.90 
Nowmber 12.5.00 llS.70 94.20 72.00 
Mean 123.63 117.23 93.43 611.70 
SD 0.93 I.IS 0.94 1.79 
CV 0. 7S 0.98 1.01 2.57 
Nou: SD-Standard Deviat.ion: CV-Coefficient ol Variat.ion. 
Source: Calculated from lb< een. .. ol Monufactu,...., 1972, 1977, 1982 and 1987. US Dcp1. ol Commerce. Bureau al Ca-. 
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°' w 
SIC Codeo J693• 
Region 1972 1m 1982 
NORniEAST 43 19 74 
"or Toe.I 41 33 23 
New Enpxl 12 31 3S 
Middle Atlantic: 31 48 39 
NORni CEl'nltAL 2S 49 S3 
'or Toe.I 24 20 20 
E. North Centr.r 22 40 40 
W. NorthC-tral 3 9 13 
sourn 
'or Toe.I 
S. Allanlic 
E. South Centnil 
w. Soulh Central 
WEST 
"or Toe.I 
Mountain 
Pecir1e 
USA 
6 
6 
s 
2S 
24 
3 
22 
104 
47 
19 
13 
29 
s 
68 
23 
9 
S9 
243 
42 
16 
24 
18 
74 
23 
12 
62 
261 
T.tile S.3(a) 
Geognipbic81 Patierno or the Medical Supply lndllltry Establishment (1972-1987) 
3841 
1972 1m 1982 
204 220 2S6 
40 ;\4 30 
n 76 93 
132 I« 163 
123 ISi 190 
24 23 22 
8S IOI 123 
38 so 62 
(IJ 
14 
40 
II 
18 
9S 
IS 
47 
II 
J7 
129 
IS 
7J 
J 
SJ 
3842 
1987 1972 1m 
30S 2S7 291 
27 29 2S 
110 62 88 
ICJS ICJS 203 
242 238 232 
21 27 24 
166 173 217 
76 6S 6S 
Im 
18 
119 
18 
6S 
210 
24 
llS 
J7 
S8 
262 
2J 
124 
SI 
87 
110 
22 
IJ 
97 
149 
23 
II 
138 
262 JJI 168 188 
JI 29 19 16 
46 S7 28 2S 
216 274 140 163 
S06 6SO 859 1136 873 llSJ 
3843 
1982 1987 1972 1977 
362 370 136 148 
26 2S J2 27 
110 104 IS 17 
2S2 266 121 131 
326 )6) 102 98 
24 24 24 18 
246 2n 79 84 
80 91 2.4 14 
Jl9 
23 
189 
60 
70 
389 
26 
220 
67 
102 
2n JIS 
20 21 
SJ 63 
224 2S2 
1367 ISOO 
so 
12 
30 
141 
3J 
20 
121 
429 
11 
2 
6 
162 
29 
10 
IS? 
sso 
No4e: Statittiao la<..- llaln h.,.,. been witht..ld 10 awid dioclooing dala la< indMdual companin by Census or Manufectu"'a. 
•sic 311« and SIC 3845 did no4 exitl until 1987 . .. SIC 3flJJ .,._d 10 ellitt alter 1987. 
Soun:e: Computed lromThe Censuoor Manuladureo, 1972. 19n. 1982 and 1987. US Dept orCommen:e, Bu...,au orCenous. 
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Ill 19 S8 
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10 10 24 
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34 
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SIC384 
1972 1m 19112 
640 738 817 
33 23 27 
161 212 2S7 
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488 S80 6S8 
26 22 22 
3S8 442 4119 
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18 
190 
48 
76 
41S 
16 
1119 
97 
S90 
S22 
18 
JIS 
66 
141 
1987 
863 
2S 
?SB 
~ 
7S7 
22 
S60 
197 
69S 
20 
407 
88 
200 
148 
29 
10 
138 
16 
21 
J 
13 
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establishments, total employment and value added. 10 National 
change of population distribution may partly explain this 
regional shift. The West has increased its share of the 
national population from 18.34% to 20.42% from 1977 to 1987 
{Table 5.4), while the Northeast and North Central regions 
both decreased their shares of the national population. 
5.4 Is Flexibility Occurring in the Medical Supply Industry? 
Using the definition of flexibility as a term indicating 
a spatially dense network of related small, vertically 
disintegrated firms with small batch production, this section 
argues that while the medical supply industry has some 
manifestations of flexibility, the whole industry cannot be 
considered "flexible". The reasons are substantiated as 
follows. 
5.4.1 Industry Strategies 
In general, the strong performance of the medical supply 
industry during the past two decades is attributable to its 
innovative strategies for coping with the changing 
environment. These strategies can be grouped into three types: 
1) continual technological innovation to make products more 
competitive; 2) targeting new markets, such as non-hospital 
markets, geriatric markets, drug markets, and foreign markets 
10 With the exception of the south increasing its share 
of establishments from 5.77% in 1972 to 16.1% in 1987, and the 
Northeast increasing its share in total employment from 21.49& 
to 26.52% during the same period of time. 
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Table 5.4 
Population by Regions (in Thousands) 1977-1987 
Region 1977 1982 1987 
• 
NORTHEAST 49282 49304 50301 
% of Total 22.43 21.27 20.66 
New England 12239 12428 12845 
Middle Atlantic 37043 36876 37456 
NORTH CENTRAL 58363 58926 59547 
% of Total 26.56 25.42 24.46 
E. North Central 41381 41582 41923 
W. North Central 16982 17344 17624 
SOUTH 71816 78438 83880 
% of Total 32.68 33.84 34.46 
S. Atlantic 35293 38307 41708 
E. South Central 14236 14862 15288 
W. South Central 22287 25269 26884 
WEST 40299 45152 49698 
% of Total 18.34 19.48 20.42 
Mountain 10402 12068 13171 
Pacific 29897 33084 36527 
,. USA 219760 231822 243427 
Source: Computed from Statistical Abstract of the United States, 1986 and 1991. 
US Dept. of Commerce, Bureau of Census. 
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to gain more profit; 3) innovative contract strategies to 
maintain market share. While the first two strategies are 
related to flexibile specialization, these strategies are not 
being implemented through small firm production, small batch 
production, or agglomerated firms as would be the case with 
flexible specialization. 
5.4.2 The Production Process 
Al though the industry in general has made tremendous 
efforts to introduce new technologies and new product process 
innovations, many firms still manufacture devices or equipment 
using old fashioned methods. The flexibility thesis' argument 
that high-tech is heavily involved in the production process 
is not an appropriate characterization of this case. 
However, the industry seems to show a new form of 
flexibility. This new form of flexibility is characterized by 
firms using unsophisticated, easy to operate machines to 
produce different products. Many small firms use this strategy 
to achieve success as niche players. This opens another 
channel to look at the whole flexibility debate. 
5.4.3 Pina size 
National data indicate the medical supply industry 
consists mainly of small and medium-sized establishments (see 
Table 4.2). About 87% of firms in the industry employ less 
than 100 people. Of the five firms interviewed, four employed 
fewer than 100 persons. However, these firms' small size is 
not recent. Some of these firms were founded as a family 
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business, while other were founded for the production of a 
single product. All were established long before the claimed 
shift to flexible specialization occurred. To argue that 
flexibility has led to an increase in the number of small and 
medium-sized establishments would be a misinterpretation. 
5.4.4 Location Factor 
Although national data (see Table 5.3(a), 5.3(b), 5,3(c)) 
indicate the West region increased its share in the industry 
during the past two decades, location is not very important in 
the industry's decision-making process. The broad locational 
decisions of the firms interviewed were based more on 
historical legacies, availability of new facilities, and 
personal ties. However, two things the firms share are 
availability of good labor and proximity to Boston, the 
predominant medical R&D center. In other words, the firms may 
agglomerate but not for the convenience of sharing information 
as the flexibility theory suggests. 
5.4.5 The Labor Process 
According to national data, the seasonal variability of 
the number of employees in the industry has dropped during the 
past two decades (see Table 5. 2) . The interviews further 
support this finding. Relations between labor and management 
are generally harmonious. Both sides prefer to maintain long 
time, stable, friendly relationships. This is evidenced by low 
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labor turnover rates11 which contradicts the claim that 
flexible labor processes are characterized by more part-time 
workers and high labor turnover rates. 
Moreover, wage scales for the companies interviewed are 
relatively stable. Many of companies stated that they have an 
above-average wage. This again contradicts the claim of wages 
becoming more flexible or being low. 
In summary, the medical supply industry has successfully 
coped with different factors during the past two decades. 
Although the industry has shown some signs of flexibility, it 
cannot be considered as "flexible specialized". For example, 
the firms do achieve flexibility by using multipurpose 
machines to produce different products for different markets. 
Small and medium-sized firms are prevalent, but this has been 
an historical phenomenon. Firms do agglomerate to gain access 
to good labor and medical R&D centers, but not for sharing 
information. Most firms have low labor turnover rates and 
above-average wages. This is not the case flexible 
specialization claims. 
11 Some workers in some firms we interviewed have stayed 
in the firm for 30 years. 
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Chapter Six 
Policy Implications 
Unlike the textile finishing industry (Nisbet, 1991), the 
medical supply industry has undergone substantial growth 
during the last two decades. It has created many jobs and has 
a substantial trade-surplus. The industry is expected to 
continue growing in the years ahead (S&P, 1991). The success 
of this industry is based on its continued involvement in 
developing new products and new methods of production; 
recruiting, maintaining and continuously training a good and 
stable workforce; strong marketing efforts, both domestically 
and internationally; achieving "flexibility" by using 
multipurpose machines to produce different products for 
different markets. What we have learned is of significance for 
policy-making. Several recommendations following the analysis 
are presented. 
First of all, to maintain economic growth and stability 
and to increase income, government should invest more in R&D 
programs in the medical supply industry since the success of 
the industry is mainly based on its leading position in 
introducing new products and new technologies. Moreover, the 
industry has to face more and more intensive challenges from 
competitors in other developed countries, such as Japan and 
the West European countries, which receive a considerable 
amount of government financial assistance in 
71 
developing new products and new technologies (S&P, 1991) 12 • 
Specific policies include three areas. First, government 
should allocate funds for R&D programs in the medical supply 
industry through budgeting. This could be achieved through 
direct investment in the industry or by providing loan 
guarantees to companies. This would enable the U.S to maintain 
its competitive edge in the market place. 
Secondly, investments in R&D should be intentionally 
concentrated among universities, research institutions, 
hospitals, medical schools and those medical supply companies 
involved in R&D. Special attention should be given to those 
organizations which are spatially concentrated thereby 
creating centers for research and applications of medical 
devices. As evidenced by the interviews, all firms clustered 
around the Boston area are able to react quickly to the 
changes in product requirements and new technological 
developments. 
Thirdly, a commission should be formed which would 
evaluate and monitor R&D programs in terms of their 
effectiveness and viability. The commission would also develop 
a strategic plan, manage the budget, and address specific 
issues in R&D programs associated with the industry. Special 
focus should be given to a product's growth potential, amount 
of value-added, compatibility with labor force skills, 
12 This concern was also expressed by some of the 
managers interviewed for this project. 
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compatibility with the environment, and job generating 
potential. 
The second recommendation relates to labor. As evidenced 
by the interviews, companies have stayed in New England 
principally because of the availability of good labor with 
metal-working experience. However, with continual 
technological innovation being the key to success in the 
medical supply industry, the industry will need to move beyond 
simple machine shop operations to remain competitive. 
Therefore, upgrading the local labor force with more advanced 
machining skills will help both the industry and the region 
remain competitive. 
Several specific policies follow. First of all, 
government should encourage traditional training ins ti tut ions, 
such as technical training programs and community colleges, 
and new training schools to contract with private industry in 
developing, planning, and designing training programs and 
curricula that will meet the industry's anticipated needs. 
This is extremely crucial for training requiring specialized 
equipment, facilities or experienced trainers. 
Secondly, government should pursue long term training 
contracts between the industry and job training institutions, 
thereby encouraging the industry to hire program graduates. 
Moreover, government should promote information exchanges 
between the industry and job training institutions. As we 
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found in the interviews, some firms have experienced 
difficulties in finding good labor. 
Thirdly, government should encourage employers to provide 
a commitment to child care options for their employees by 
providing child-care support in the employee benefits package, 
as well as locating day care facilities near or in the work 
place. From our interviews, due to the unique feature of the 
industry, we found firms in the industry hire considerable 
number of workers who are in their 20s to 40s. Providing child 
care facilities will release the double burden on working 
parents and thereby improve the availability of labor. 
Last but not least, policy should support small and 
medium-sized businesses. As we discovered in our analysis, the 
medical supply industry consists mainly of these companies. 
These companies contribute to the economy through their 
successful operation as niche players. These small businesses 
are an important source for the growth and stability of the 
economy. However, these firms also experience different 
pressures and difficulties. Some lack financial ability--, 
Many do not issue public stock--, and few have long-term 
plans. Therefore, compared with large firms, small businesses 
have less ability to pass on cost due to inflation, and have 
difficulty investing in the development of new products and 
new technology, and are less able to deal with 
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the continually complicated legislation concerning the 
industry. 
Government could assist these firms in at least the 
following ways. First of all, government could support and 
assist small business with start-up and expansion by providing 
technical and information resources and by aiding in capital 
formation through low interest loans. Secondly, government 
could provide technical assistance, helping businesses to 
identify problems and solutions before problems become severe, 
and assist in the development of stabilization and expansion 
plans with realistic background information and figures. 
Thirdly, government should assist small business in fulfilling 
legal requirements. Many small firms interviewed complained 
about red-tape and tedious procedures in dealing with 
government regulations. Complex procedures have made it 
necessary for small firms to hire personnel solely for dealing 
with legal issues. However, not all small firms can afford to 
do this. Therefore, a coordinated effort by government to 
assist these small firms could certainly enhance the 
competitiveness of the firms and improve the profit rate of 
the firms. For example, government could create legal 
coordinator(s) to provide information on legal issues and to 
help small firms solve any regulatory problems. 
The flexibility debate also impacts planning as a 
discipline. First, the flexibility debate undoubtedly enhances 
the academic development of planning by adding another piece 
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of knowledge to our understanding of how communities and 
regions develop. 
Second, the flexibility debate would also impact planning 
education because of its implicit challenge to some forms of 
planning education. Should planning students be required to 
know more about political economy and industrial organization? 
What background knowledge should planning students possess to 
deal with more and more complex planning issues? All in all, 
these are the questions that planning educators must face. 
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